Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Biochemical Studies on the Role of Curcumin in the Protection of Liver and Kidney Damage by Anti-Malaria Drug, Chloroquine


Affiliations
1 Institute of Biological Sciences, University of Malaya, Kuala Lumpur 50603, Malaysia
2 Jordanian University of Science and Technology, Jordan
     

   Subscribe/Renew Journal


Some parts of Malaysia are endemic areas, whereas malaria exists and its control has become a formidable task. Chloroquine phosphate (CQ) on account of its rapid action on blood schizontocide of all the malarial parasite strains has become the most widely prescribed drug for prophylaxis and treatment of malaria. Toxicity of CQ is most commonly encountered at therapeutic and higher doses of treatment. Thus, the present study was undertaken to evaluate the protective effect of curcumin, a herbal antioxidant obtained from Curcuma Tonga, on hepatic and renal biochemical status of CQ-induced Balb/c mice. It has been shown that administration of CQ brought about a significant decrease in antioxidant enzymes, catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GSHpx) activities, whereas alanine aminotransferase (ALT) activity was found to be significantly increased following CQ treatment. Lipid peroxidation (LPO) was found to be elevated in a significant manner in the CQ treated group as compared to control. Body, liver and kidney weights declined significantly following CQ treatment. Administration of curcumin exhibited significant reversal of CQ induced toxicity in hepatic and renal tissues. Thus obtained results led us to conclude that curcumin has a highly protective power against CQ toxicity and the protective action relates, at least in part to its direct free radical scavenging ability.

Keywords

Chloroquine, Curcumin, Antioxidant, Liver Damage, Kidney Damage.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Borba E.F., J.R. Turrini, M.E. Pedalini and E. Bonfa, 2004. Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry. Lupus, 13: 223-227.

  • Romanelli F., K.M. Smith and A.D. Hoven, 2004. Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus activity. Curr. Pharm. Res. 10: 2643-2648.

  • Nasreddin W. and A. Beydoun, 2007. Oxcarbazepine in neuropathic pain. Expert opinion on investigational drugs. 16: 1615-1625.

  • Santos N.A., W.S. Medina, N.M. Martins, M.A. Rodrigues, C. Curti and A.C.Santos, 2008. Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs. Toxicology in vitro. 22: 1820-1824.

  • Ahmed S.N. and Z.A. Siddiqi, 2006. Antiepileptic drugs and liver disease. Seizur, 15: 156-164.

  • Zegura, B., T. Tamara and M. Filipic, 2004. The role of reactive oxygen species in microcystin-LR-induced DNA damage. Toxicol., 200: 59-68.

  • Weng, D., Y. Lu, Y. Wei, Y. Liu and P. Shen, 2007. The role of ROS in microcystin-LR-induced hepatocyte apoptosis and liver injury in mice. Toxicol., 232: 15-23.

  • Halliwell B., J.M.Gutteridge, C.E. Cross, 1992. Free radicals, antioxidants and human diseases. J. Lab. Clin. Med. 119: 598620. 20

  • Louise M.W., M.K. Perry and AN. Jac, 2003. Oxidative stress-induced homologous recombination as a novel mechanism for phenytoin - initiated toxicity. JPET, 306: 523-527.

  • Lee W.M., 1995. Drug-induced hepatotoxicity. N. Engl. J. Med., 333: 1118- 1127.

  • Naik R.S., A.M. Mujumdar and S. Ghaskadbi, 2004. Protection of liver cells from ethanol cytotoxicity by curcumin in liver slice culture in vitro. J. Ethnopharmacology. 95: 31 - 37.

  • Johnson J.J. and H. Mukhtar, 2007. Curcumin for chemoprevention of colon cancer. Cancer Lett., 255: 170-181.

  • Eybl, V., D. Kotyzova, P. Cerra and J. Koutenski, 2008. Effect of melatonin, curcumin, quercetin and resveratrol on acut ferric mtrilotriacetate-induced renal oxidative damage in rats. Human&Exiperimental Toxicol., 27: 347-353.

  • Walla K.S., E.A. Khan, D.H. Ko, S.S. Raza and N.Y. Khan, 2004. Side effects of antiepileptics- a review. Pain Practice, 4: 194-203.

  • Ak, T. and I. Gulcin, 2008. Antioxidant and radical scavenging properties of curcumin. Chemico- Biological Interactions, 174: 27-37.

  • George, J. and G.C. Farrell, 1999. Anticonvulsivant hepatotoxicity. In: Farrell, G.C.(Ed.), Drug - induced liver disease. Edinburgh, Churchill Livingston, London, pp: 134-144.

  • Chang, T.K.H. and F. S. Abbott, 2006. Oxidative stress as a mechanism of valproic acid - associated hepatotoxicity. Drug Metabolism Revi, 38: 627-639.

  • Amacher D.E.,2002. A toxicologists guide to biomarkers of hepatic response. Hum. Exp. Toxicol., 21:253-262.

  • Kaplowitz,N.,2005.Idiosyncraticdrug hepatotoxicity. Nature Revi., 4: 489-499.

  • Scott, E.M. and J.P. Harrington, 1990. Comparative studies of catalase and superoxide dismutase activity within salmon fish erythrocytes. Comp. Biochem. Physiol., 95B: 91-93.

  • Stief, T.W., 2003. The physiology and pharmacology of singlet oxygen. Med. Hypotheses, 60: 567-572.

  • Leopold, F. and A. Wolfgang, 1984. Assays of glutathione peroxidase. Methods in Enzymol., 105: 115-121.

  • Hussaini,S.H. and E.A. Farrington,2007. Idiosyncratic drug-induced liver injury: an overview. Expert Opinion on Drug Safety, 6: 673-684.

  • Roy, D. and W.R. Snodgrass, 1988. Phenytoin metabolic activation: role of cytochrome P-450, glutathione, age and sex in rats and mice. Research communications in chemical pathology and pharmacol., 59: 173-190.

  • Al-Jassabi, S. and A. Khalil, 2006. Microcystin- induced 8- Hydroxydeoxyguanosine in DNA and its Reduction by Melatomn, Vitamin C and Vitamin E in Mice. Biochemistry (Moscow), pp: 1377-1382.

  • Collins, A.R., M. Dusinska, C.M. Gedik and R. Stitina, 1996. Oxidative damage to DNA: do we have a reliable biomarker?. Environ. Health Perspect., 104: 465-469.

  • Driefus, F.E. and D.H. Langer, 1987. Hepatic considerations in the use of antiepileptic drugs. Epilepsia, 28: S23-S29.

  • Sega, Y., F. Nishimura and Y. Ohtsuka, 2004. CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects. Life Sci., 74: 827-834.

  • Zwanzger, P., D. Eser and R. Rupprecht, 2007. Anticonvulsants in the treatment of anxiety-an alternative treatment option? Der Nervenarzt, 78:1274-1282.

  • Ding W.X., H.M. Shen and C.N. Ong, 2000. Critical role of reactive oxygen species and mitochondrial permeabilitytransition in microcystin-induced rapid apoptosis in rat hepatocytes. Hepatol., 32: 547-555.

  • Nitti, M., M.A. Pronzato, U.M. Marinari and C. Domenicotti, 2008. PKC signaling in oxidative hepatic damage. Molecular Aspects of Medicine, 29: 36-42.

  • Reddy, S.S., V.M. Subramanyam, R. Vani and S.A. Devi, 2007. In vitro models of oxidative stress in rat erythrocytes: Effect of antioxidant supplements. Toxicology in vitro., pp: 1-17.

  • Xu, G.W., Q.H. Yao, Q.F. Weng, B.L. Su, X. Zhang and J.H. Xiong, 2004. Study of urinary 8-hydroxydeoxyguanosineasabiomarker of oxidative DNA damage in diabetic nephropathy patients. J. Pharmaceutical and Biomedical Analysis, 36: 101-104.

  • Abdel-Zaher,A.O.,R.H. Abdel-hady, M.M. Mahmoud and M.Y. Farrag, 2008. The potentialroleof alph-lipoicacidagainst acetaminophen- induced hepatic and renal damage. Toxicol., 243: 261-270.

  • Cadet, J., A.G. Bourdat, C. Ham, V. Duarte, D. Gasparutto, A. Romieu and J.L. Ravanat, 2000. Oxidative base damage to DNA: specificity of base excision repair enzymes. Mutat. Res., 462: 121-128.

  • Tomoko, K., Y. Hiroshi and N. Miki,2002. Identification of catalase in human liver as factor that enhances phenytoin dihydroxy metabolite formation by human liver microsomes. Biochemical Pharmacol., 63: 2081-2090.

  • Ozer, J., M. Ratner, M. Shaw, W. Baily and S. Schomaker, 2008 The current status of serum biomarkers of hepatotoxicity. Toxicol., 244: 194-205.

  • Susa, N., S. Ueno, Y. Furukawa, J. Ueda and M. Sugiyama, 1997. Protein protective effect of melatonin on chromium (VI)-induced DNA single strand breaks, cytotoxicity and lipid peroxidation in primary cultures of rat hepatocytes. Toxicol. Appl. Pharmacol., 144: 377- 384.

  • Kunnumakkara, A., P. Anand and B.B. Aggarwal, 2008. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple - cell signaling proteins.CancerLett., 269: 199-225.

  • Sperati, A., D.D. Abem, C. Tagesson, F. Forastiere, M. Miceli and O. Axelson, 1997. Exposure to indoorbackgroundradiationandurinary concentration of 8-OH-dG, a marker of oxidative DNA damage. Carcinogenesis, 19: 233-241.

  • Suresh, D. and K. Srimvasan, 2007. Studies on the in vitro absorption of spice principles Curcumin, capsaicin and piperine in rat intestines. Food and Chemical Toxicol., 45: 1437-1442.

  • Roberts, C., M.T. Harvey, M.E. May, T.G. Patterson, M.H. Couppis and C.H. Kennedy, 2008. Varied effects of conventional antiepileptics on responding maintained by negative versus positive reinforcement. Physiology and Behavior. 93: 612-621.

  • Nelson, M.H., A.K. Birnbaum and R.P. Rommel, 2001. Inhibition ofphenytoinpharmacokinetics following oral administration of phenytoin suspention and fosphenytoin solution to rats. Epilepsy Res., 44: 71-82.

  • Sakamoto, W., H. Isomura, K. Fujie, J. Nishihira, M. Ozaki and S. Yakawa, 2003. Coffee increases level of urinary 8-hydroxydeoxyguanosine in rats. Toxicol., pp: 255-263.

  • Schuler, D., M. Otteneder, P. Sagelsdorff, R.C. Gupta and W.K. Lutz, 1997. Comparative analysis of 8-oxo- 2-deoxyguanosine in DNA by 32P and 33P- post labelingandelectrochemicaldetection. Carcinogenesis, 18: 2367-2371.

  • Tsou, T.C., C.L. Chen, T.Y. Liu and J.L. Yang, 1996. Induction of 8-hydroxydeoxyguanosine in DNA by chromium (III) plus hydrogen peroxide and its prevention by scavengers. Carcinogenesis, 17:103-108. 22

  • An, J. and W.W. Carmichael,1994. Use of colorimetric protein phosphatase inhibition assay and enzyme-linked lmmunosorbent assay for the study of microcystin and nodularins. Toxicon., 32: 1495-1507.


Abstract Views: 283

PDF Views: 2




  • Biochemical Studies on the Role of Curcumin in the Protection of Liver and Kidney Damage by Anti-Malaria Drug, Chloroquine

Abstract Views: 283  |  PDF Views: 2

Authors

S. Aljassabi
Institute of Biological Sciences, University of Malaya, Kuala Lumpur 50603, Malaysia
Mohd Sofian Azirun
Institute of Biological Sciences, University of Malaya, Kuala Lumpur 50603, Malaysia
Ali Saad
Jordanian University of Science and Technology, Jordan

Abstract


Some parts of Malaysia are endemic areas, whereas malaria exists and its control has become a formidable task. Chloroquine phosphate (CQ) on account of its rapid action on blood schizontocide of all the malarial parasite strains has become the most widely prescribed drug for prophylaxis and treatment of malaria. Toxicity of CQ is most commonly encountered at therapeutic and higher doses of treatment. Thus, the present study was undertaken to evaluate the protective effect of curcumin, a herbal antioxidant obtained from Curcuma Tonga, on hepatic and renal biochemical status of CQ-induced Balb/c mice. It has been shown that administration of CQ brought about a significant decrease in antioxidant enzymes, catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GSHpx) activities, whereas alanine aminotransferase (ALT) activity was found to be significantly increased following CQ treatment. Lipid peroxidation (LPO) was found to be elevated in a significant manner in the CQ treated group as compared to control. Body, liver and kidney weights declined significantly following CQ treatment. Administration of curcumin exhibited significant reversal of CQ induced toxicity in hepatic and renal tissues. Thus obtained results led us to conclude that curcumin has a highly protective power against CQ toxicity and the protective action relates, at least in part to its direct free radical scavenging ability.

Keywords


Chloroquine, Curcumin, Antioxidant, Liver Damage, Kidney Damage.

References